QWQiqi Wang

Qiqi Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Qiqi Wang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Chongshan Dai

    State Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China

    1 shared publication
  • Haiyang Jiang

    State Key Laboratory of Veterinary Public Health and Safety, Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China

    1 shared publication
  • Jiankang Ren

    State Key Laboratory of Veterinary Public Health and Safety, Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China

    1 shared publication
  • Jianzhong Shen

    State Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University

    1 shared publication
  • Tony Velkov

    Department of Pharmacology, Monash Biomedicine Discovery Institute, Monash University

    1 shared publication
  • Yunpeng Yi

    Shandong Provincial Key Laboratory of Livestock and Poultry Breeding, Institute of Poultry Science, Shandong Academy of Agricultural Science

    1 shared publication

Latest Publications

  • Open Access

    Progress of AI-Driven Drug–Target Interaction Prediction and Lead Optimization

    by Qiqi Wang, Boyan Sun, Yunpeng Yi, Tony Velkov, Jianzhong Shen, Chongshan Dai, Haiyang Jiang

    In modern pharmaceutical research and development (R&D), drug discovery remains a challenging process. Artificial intelligence (AI) has been extensively incorporated into various phases of drug discovery and development. AI enable effectively extract molecular structural features, perform in-depth analysis of drug–target interactions, and systematically model the relationships among drugs, targets, and diseases. These approaches improve prediction accuracy, accelerate discovery timelines, reduce costs from trial and error methods, and enhance success probabilities. This review summarizes recent advances in AI applications for drug design, including target identification, synthetic accessibility prediction, lead optimization, and ADMET property evaluation. Furthermore, it introduces various deep learning tools to guide researchers in selecting and implementing the most appropriate AI-driven strategies throughout the drug discovery process. We hope it can establish a conceptual framework intended to advance AI-driven methodologies in pharmaceutical research by comprehensively organizing novel perspectives and critical insights.